GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » 5-Year Yield-on-Cost %

Rohto Pharmaceutical Co (TSE:4527) 5-Year Yield-on-Cost % : 1.82 (As of Apr. 27, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co 5-Year Yield-on-Cost %?

Rohto Pharmaceutical Co's yield on cost for the quarter that ended in Dec. 2023 was 1.82.


The historical rank and industry rank for Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

TSE:4527' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.08   Med: 1.74   Max: 2.72
Current: 1.82


During the past 13 years, Rohto Pharmaceutical Co's highest Yield on Cost was 2.72. The lowest was 1.08. And the median was 1.74.


TSE:4527's 5-Year Yield-on-Cost % is ranked worse than
66.58% of 1095 companies
in the Consumer Packaged Goods industry
Industry Median: 2.84 vs TSE:4527: 1.82

Competitive Comparison of Rohto Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.



Rohto Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Rohto Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Rohto Pharmaceutical Co  (TSE:4527) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Rohto Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co (TSE:4527) Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines